Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 7, 2007, Pages 805-812

  Takenaka, R ^a,b   Okada, H ^b   Kato, J ^b   Makidono, C ^b   Hori, S ^b   Kawahara, Y ^b   Miyoshi, M ^c   Yumoto, E ^d   Imagawa, A ^e   Toyokawa, T ^f   Sakaguchi, K ^b   Shiratori, Y ^b  

^a Graduate School of Medicine Dentistry and Pharmaceutical Sciences ^*  (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c KURASHIKI CENTRAL HOSPITAL   (Japan)

^d Sumitomo Besshi Hospital   (Japan)

^e Tsuyama Central Hospital   (Japan)

^f Mitoyo General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE CANCER; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER;

AGED; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 33947224229     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03268.x     Document Type: Article

References (27)

1. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
2. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
3. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
4. Sipponen P, Kekki M, Haapakoski J, et al. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-7.
5. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19: S37-43.
6. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94.
7. Take S, Mizuno M, Ishiki K, et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005; 100: 1037-42.
8. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
9. Yoshimura T, Shimoyama T, Fukuda S, Tanaka M, Axon ATR, Munakata A. Most gastric cancer occurs on the distal side of the endoscopic atrophic border. Scand J Gastroenterol 1999; 34: 1077-81.
10. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169-79.
11. Nozaki K, Shimizu N, Ikehara Y, et al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 2003; 94: 235-9.
12. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-5.
13. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-8.
14. Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 2001; 6: 294-9.
15. Eto K, Ohyama S, Yamaguchi T, et al. Familial clustering in subgroups of gastric cancer stratified by histology, age group and location. Eur J Surg Oncol 2006; 32: 743-8.
16. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti- Helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-188.
17. Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 380-6.
18. Chan AO, Peng JZ, Lam SK, et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006; 55: 463-8.
19. Leung WK, Man EP, Yu J, et al. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 2006; 12: 3216-21.
20. Chang YW, Jang JY, Kim NH, et al. Interleukin-1β (IL-1β) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 2005; 114: 465-71.
21. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003; 104: 617-23.
22. Lee WP, Tai DI, Lan KH, et al. The - 251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 2005; 11: 6431-41.
23. Sugimoto M, Furuta T, Shirai N, et al. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther 2005; 22: 1033-40.
24. Ottini L, Palli D, Falchetti M, et al. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 1997; 57: 4523-9.
25. Tahara E. Molecular biology of gastric cancer. World J Surg 1995; 19: 484-8.
26. Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998; 58: 4086-9.
27. Kamada T, Hata J, Sugiu K, et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005; 21: 1121-6.